Emergency Use Authorization

Emergency Use Authorization (EUA) is an authorization issued for unregistered drugs and vaccines in a public health emergency. The FDA Director General, by virtue of the Executive Order No. 121 of the President of the Philippines, authorizes the issuance of the EUA.

List of COVID-19 Vaccines Authorized by the FDA

• Pfizer-BioNTech/Comirnaty COVID-19 mRNA Vaccine (nucleoside modified)
• ChAdOx1-S[recombinant] VAXZEVRIA (COVID-19 Vaccine AstraZeneca)
• SARS-CoV-2 Vaccine (Vero Cell), Inactivated [Coronavac]
• Sputnik V Gam-COVID-Vac/Sputnik Light COVID-19 Vaccine
• Janssen COVID-19 Vaccine (Ad26.COV2-S (recombinant))
• Whole Virion, Inactivated Corona Virus Vaccine [Covaxin]
• COVID-19 mRNA Vaccine (nucleoside modified) [COVID-19 Vaccine Moderna]
• COVID-19 Vaccine (Vero Cell), Inactivated [COVID-19 Vaccine Sinopharm]
• SARS-CoV-2 rS Protein Nanoparticle Vaccine [Covovax]

List of COVID-19 Drugs Authorized by the FDA

Reports of suspected adverse reaction to COVID-19 vaccines

The FDA publishes overview of reports of suspected adverse reaction to COVID-19 vaccines currently in use in the vaccination program of the Philippines. The FDA issues weekly overview of the reports.

Status as of 26 June 2022

Number of individuals partly vaccinated:  4,857,898
Number of fully vaccinated individuals: 70,358,612
Number of reports of suspected adverse reaction: 103,426 (0.07% of doses administered)

• as of 26 June 2022
• as of 19 June 2022
• as of 12 June 2022
• as of 05 June 2022

To report a suspected side effect, click here.